Biopac India Corporation Ltd vs BHEL
A side-by-side comparison of Biopac India Corporation Ltd (532330) and BHEL (BHEL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, BHEL leads 532330 vs BHEL on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth· not comparable—
- Size & financial health13
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
BHEL takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
BHEL takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -39.1% over past five years."]
- + ["Company is expected to give good quarter", "Company has delivered good profit growth of 20.9% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 31.3%"]
- − ["Stock is trading at 5.74 times its book value", "Company has a low return on equity of 3.18% over last 3 years.", "Promoter holding has decreased over last 3 years: -5.00%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.